Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease

Area of Science:

• Cardiology
• Adult Congenital Heart Disease
• Heart Failure Management

Background:

• Adults with congenital heart disease (ACHD) present unique challenges in managing advanced heart failure (HF).
• Current treatment paradigms for HF may not be fully applicable to the ACHD population.
• Multidisciplinary care is essential for optimizing outcomes in these complex patients.

Purpose of the Study:

• To review current management strategies for advanced heart failure in adults with congenital heart disease.
• To evaluate the roles of heart transplantation and mechanical circulatory support (MCS) in ACHD patients with HF.
• To identify barriers and facilitators for utilizing advanced therapies in this population.

Main Methods:

• Review of current literature and clinical data on heart transplantation and MCS in ACHD.
• Analysis of survival rates, quality of life, and utilization patterns.
• Assessment of current listing criteria and their applicability to ACHD.

Main Results:

• Adults with ACHD experience higher short-term mortality post-transplant or MCS implantation but achieve superior long-term survival.
• ACHD patients are less likely to receive heart transplants due to limitations in current listing criteria.
• Mechanical circulatory support (MCS) is underutilized but offers comparable quality of life benefits for ACHD and non-ACHD patients.
• Advanced HF in ACHD is complex, with transplantation and MCS implementation posing significant challenges.

Conclusions:

• Despite challenges, heart transplantation and MCS are viable and encouraging options for advanced HF in ACHD.
• Earlier consideration of MCS and heart transplantation is supported by long-term data.
• Optimizing outcomes requires addressing current listing criteria limitations and increasing MCS utilization.
• Integrated, multidisciplinary care is paramount for successful management of advanced HF in ACHD.